Xp11.2/TFE3 translocation-associated renal cell carcinoma with multilocular cystic structures in an elderly patient: a case report

被引:0
|
作者
Sawazumi, Tomoe [1 ]
Kato, Ikuma [3 ]
Tanaka, Mio [4 ]
Tanaka, Yukichi [4 ]
Yamanaka, Shoji [1 ]
Kuroda, Naoto [5 ]
Yao, Masahiro [2 ]
Nagashima, Yoji [6 ]
Ohashi, Kenichi [1 ,3 ]
机构
[1] Yokohama City Univ Med, Dept Anat & Surg Pathol, Yokohama, Kanagawa, Japan
[2] Yokohama City Univ Med, Dept Anat & Surg Urol, Yokohama, Kanagawa, Japan
[3] Yokohama City Univ, Grad Sch Med, Dept Mol Pathol, Yokohama, Kanagawa, Japan
[4] Kanagawa Childrens Med Ctr, Dept Pathol, Yokohama, Kanagawa, Japan
[5] Kochi Red Cross Hosp, Dept Diagnost Pathol, Kochi, Japan
[6] Tokyo Womens Med Univ Hosp, Dept Surg Pathol, Tokyo, Japan
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2016年 / 9卷 / 03期
关键词
Xp11.2/TFE3 translocation-associated renal cell carcinoma (Xp11.2-RCC); elderly; multilocular cystic structures; TFE3; fluorescence in situ hybridization (FISH); BREAK-APART FISH; TFE3;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Xp11.2 translocation-associated renal cell carcinomas (Xp11.2-RCCs) are a rare subtype of renal neoplasm. The incidence of these tumors is lower in the elderly than in children and young adults. Furthermore, there have been very few reports of Xp11.2-RCCs with multilocular cystic structures. Case: A 66-year-old Japanese female was admitted to our hospital with amultilocular cystic lesion in her right kidney. Computed tomography revealed that the lesion occupied the cortex and medulla of the upper pole of the right kidney, and partial nephrectomy was performed. Resected tissue contained a multilocular cystic tumor measuring 4.5x4.3x4.0 cm. Histologically, the cyst walls were composed of thin fibrous septa covered by a few layers of tumor cells with a clear cytoplasm. Psammoma bodies were scattered in the cyst lining. Immunohistochemically, most of tumor cells were positive for TFE3, alpha-methylacyl CoA racemase (AMCAR), and cathepsin K. Tumor cells also showed immunoreactivities for CD10 and cytokeratins, but were negative for carbonic anhydrase 9 and c-kit. Fluorescence in situ hybridization using a break-apart probe revealed monoalleleic TFE3 breakage. Based on these results, the tumor was diagnosed as Xp11.2-RCC, even though the patient's age and morphological architecture were not representative. Conclusion: This case demonstrated that Xp11.2-RCCs may occur in adults with multilocular cystic structures. Retrospectively, the recognition of psammoma bodies represented an important diagnostic sign.
引用
收藏
页码:3987 / 3992
页数:6
相关论文
共 50 条
  • [31] Contrast-enhanced ultrasound findings of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma
    Wei, Shuping
    Tian, Fuli
    Xia, Qiuyuan
    Huang, Pengfei
    Zhang, Yidan
    Xia, Zhichao
    Wu, Min
    Yang, Bin
    CANCER IMAGING, 2019, 20 (01)
  • [32] Four years of natural progressive course: A rare case report of juvenile Xp11.2 translocations renal cell carcinoma with TFE3 gene fusion
    Hu, Liang
    Li, Lina
    Li, Angcheng
    Tong, Jianyong
    OPEN MEDICINE, 2024, 19 (01):
  • [33] Xp11.2 Translocation Renal Cell Carcinoma: A Rare Renal Cell Carcinoma
    Kalita, Pranjal
    Dey, Biswajit
    Saurabh, Animesh
    Chishti, Sheikh F.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)
  • [34] Renal cell carcinoma associated with Xp11.2 translocation arising in a horseshoe kidney
    Driss, Maha
    Boukadi, Alia
    Charfi, Lamia
    Douira, Wiem
    Mrad, Karima
    Bellagha, Ibtissem
    Chaouachi, Beji
    Ben Romdhane, Khaled
    PATHOLOGY, 2009, 41 (06) : 587 - 590
  • [35] Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma
    Pradhan, Dinesh
    Roy, Somak
    Quiroga-Garza, Gabriela
    Cieply, Kathleen
    Mahaffey, Alyssa L.
    Bastacky, Sheldon
    Dhir, Rajiv
    Parwani, Anil V.
    DIAGNOSTIC PATHOLOGY, 2015, 10
  • [36] Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11.2 translocation renal cell carcinoma
    Liu, Ning
    Chen, Yi
    Yang, Lei
    Shi, Qiancheng
    Lu, Yanwen
    Ma, Wenliang
    Han, Xiaodong
    Guo, Hongqian
    Li, Dongmei
    Gan, Weidong
    CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (04):
  • [37] Cytologic Features of Renal Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions: A Case Report with Voided and Catheterized Urine Cytology and a Literature Review
    Kuwamoto, Satoshi
    Murai, Yuki
    Endo, Yukari
    Masago, Toshihiko
    Kuroda, Naoto
    Horie, Yasushi
    ACTA CYTOLOGICA, 2014, 58 (04) : 406 - 412
  • [38] Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 gene fusion: A case report and literature review
    Yang, Denghao
    Tang, Wen
    Liu, Mingwen
    Xie, Zhifei
    Shi, Fei
    Zhao, Zeju
    Yang, Xiaorong
    Wu, Tao
    ONCOLOGY LETTERS, 2024, 27 (01)
  • [39] Pregnant patient with Xp11.2/transcription factor E3 translocation renal cell carcinoma: a case report and literature review
    Wang, Yanchen
    Guo, Xiaoyan
    Meng, Zhe
    Cui, Yong
    Sun, Yaofei
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [40] TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease
    Baba, Masaya
    Furuya, Mitsuko
    Motoshima, Takanobu
    Lang, Martin
    Funasaki, Shintaro
    Ma, Wenjuan
    Sun, Hong-Wei
    Hasumi, Hisashi
    Huang, Ying
    Kato, Ikuma
    Kadomatsu, Tsuyoshi
    Satou, Yorifumi
    Morris, Nicole
    Karim, Baktiar O.
    Ileva, Lilia
    Kalen, Joseph D.
    Krisna, Luh Ade Wilan
    Hasumi, Yukiko
    Sugiyama, Aiko
    Kurahashi, Ryoma
    Nishimoto, Koshiro
    Oyama, Masafumi
    Nagashima, Yoji
    Kuroda, Naoto
    Araki, Kimi
    Eto, Masatoshi
    Yao, Masahiro
    Kamba, Tomomi
    Suda, Toshio
    Oike, Yuichi
    Schmidt, Laura S.
    Linehan, W. Marston
    MOLECULAR CANCER RESEARCH, 2019, 17 (08) : 1613 - 1626